Protara Therapeutics | 8-K: Current report
Protara Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Protara Therapeutics | 8-K: Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
Protara Therapeutics | DEF 14A: Definitive information statements
Protara Therapeutics | DEFA14A: Others
Protara Therapeutics | 8-K: Current report
Protara Therapeutics | 8-K: Current report
Protara Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Protara Therapeutics | 8-K: Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Protara Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Protara Therapeutics | 8-K: Protara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
Protara Therapeutics | 8-K: Protara Therapeutics Announces Second Quarter 2023 Financial Results and Business Update
Protara Therapeutics | 8-K: Current report
Protara Therapeutics | 8-K: Protara Therapeutics Announces First Quarter 2023 Financial Results and Business Update
Protara Therapeutics | 8-K: Current report
Protara Therapeutics | 8-K: Current report
Protara Therapeutics | DEFA14A: Others
Protara Therapeutics | DEF 14A: Definitive proxy statements
Protara Therapeutics | 8-K: Current report
Protara Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data